CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Revenues:
Total revenues	$ 1,420,460	$ 1,532,782
Expenses:
General and administrative	54,231	65,956
Depreciation and amortization	6,787	6,876
Total expenses	1,416,463	1,554,892
Income (loss) from operations	3,997	(22,110)
Other income (expense):
Income (loss) from equity method investments	11,733	12,672
Other income (expense), net	16,025	9,261
Interest expense	(1,811)	(1,515)
Income (loss) before income taxes	29,944	(1,692)
Income tax benefit (expense)	(28)	(196)
Income (loss) from continuing operations	29,916	(1,888)
Discontinued operations:
Adjustments on sale of assets, net	19,000	14,000
Net income (loss) attributable to common shares	$ 48,916	$ 12,112
Basic earnings per common share:
Continuing operations (in dollars per share)	$ 1.80	$ (0.11)
Discontinued operations (in dollars per share)	1.15	0.84
Net income (loss) attributable to common shares (in dollars per share)	2.95	0.73
Diluted earnings per common share:
Continuing operations (in dollars per share)	1.80	(0.11)
Discontinued operations (in dollars per share)	1.14	0.84
Net income (loss) attributable to common shares (in dollars per share)	$ 2.94	$ 0.73
Weighted average shares outstanding
Basic (in shares)	16,599,000	16,517,000
Diluted (in shares)	16,662,000	16,517,000
Medical services revenue
Revenues:
Total revenues	$ 1,418,549	$ 1,529,879
Expenses:
Expenses	1,269,628	1,401,867
Other operating revenue
Revenues:
Total revenues	1,911	2,903
Expenses:
Expenses	$ 85,817	$ 80,193